Digital Therapeutics: The Next Frontier in Treatment & Prevention

Cost: $125
Location: BELLINI 2005-2006

At this deep dive event exploring the new frontier of digital therapeutics, DTx pioneers will share their experiences in creating, validating, and obtaining FDA approval for digital therapies. Presenters will discuss key factors in development and rollout, such as assessing market opportunities, UX and design, product positioning and working with pharmaceutical and/or traditional medical device companies. The agenda will also address market acceptance of the notion that digital products can provide therapeutic benefit as a first-line treatment, adjuvant or preventative therapy, and approaches for gaining acceptance by providers, payers and patients. The session will feature commentary on research a joint research initiative by the Personal Connected Health Alliance, the Consumer Technology Association and Ipsos Healthcare to understand the current state and direction of the field of digital therapeutics, and to explore potential opportunities for new developments in the future.

Register Now

Wednesday, March 7

Session id: 
AC18-DTX1
3:00PM - 3:10PM PST
3:20PM - 3:30PM PST
Session id: 
AC18-DTX4
3:30PM - 4:00PM PST
4:00PM - 4:15PM PST
Session id: 
AC18-DTX6
4:15PM - 4:50PM PST
Session id: 
AC18-DTX8
5:15PM - 5:25PM PST
Session id: 
AC18-DTX9
5:25PM - 5:40PM PST

WHERE THE WORLD
CONNECTS FOR HEALTH